Mark Carota

All filings by Mark Carota on record concern Dusa Pharmaceuticals Inc. In total, 36 filings cover trades dated from 9 May 2008 to 20 December 2012.

On the market, this insider has only sold: 16 sales, €153k in total. Outside the open market, there are 15 share grants and 3 option exercises.

The latest filing, published on 20 December 2012, reports a transaction of €903k in Dusa Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.